Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: PROSTATIC NEOPLASMS - MORTALITY , . Treffer: 15
2018
Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T
Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583
Doi: 10.1038/s41391-018-0068-3
Web of Science
PubMed
FullText
FullText_MUG
2017
Renner, W; Langsenlehner, U; Krenn-Pilko, S; Eder, P; Langsenlehner, T
BCL2 genotypes and prostate cancer survival.
Strahlenther Onkol. 2017; 193(6):466-471
Doi: 10.1007/s00066-017-1126-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Dalela, D; Krishna, N; Okwara, J; Preston, MA; Abdollah, F; Choueiri, TK; Reznor, G; Sammon, JD; Schmid, M; Kibel, AS; Nguyen, PL; Menon, M; Trinh, QD
Suicide and accidental deaths among patients with non-metastatic prostate cancer.
BJU Int. 2016; 118(2):286-97
Doi: 10.1111/bju.13257
Web of Science
PubMed
FullText
FullText_MUG
Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T
Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611
Doi: 10.1007/s00345-015-1646-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T
The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473
Doi: 10.1007/s00345-014-1459-2
Web of Science
PubMed
FullText
FullText_MUG
Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T
The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Eur J Cancer. 2015; 51(5):610-619
Doi: 10.1016/j.ejca.2015.01.002
Web of Science
PubMed
FullText
FullText_MUG
2014
Langsenlehner, T; Thurner, EM; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U
Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.
Strahlenther Onkol. 2014; 190(4):364-369
Doi: 10.1007/s00066-013-0503-2
Web of Science
PubMed
FullText
FullText_MUG
2010
Porter, CR; Suardi, N; Capitanio, U; Hutterer, GC; Kodama, K; Gibbons, RP; Correa, R; Perrotte, P; Montorsi, F; Karakiewicz, PI
A nomogram predicting prostate cancer-specific mortality after radical prostatectomy.
Urol Int. 2010; 84(2): 132-140.
Doi: 10.1159/000277588
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2008
Jeldres, C; Suardi, N; Walz, J; Saad, F; Hutterer, GC; Bhojani, N; Shariat, SF; Perrotte, P; Graefen, M; Montorsi, F; Karakiewicz, PI
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Eur Urol. 2008; 54(1):107-116
Doi: 10.1016/j.eururo.2007.10.038
Web of Science
PubMed
FullText
FullText_MUG
Walz, J; Suardi, N; Shariat, SF; Jeldres, C; Perrotte, P; Graefen, M; Widmer, H; Arjane, P; Valiquette, L; Hutterer, G; Saad, F; Karakiewicz, PI
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
BJU Int. 2008; 102(1):33-38
Doi: 10.1111/j.1464-410X.2008.07614.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Mohamad, BA; Marszalek, M; Brössner, C; Ponholzer, A; Wehrberger, C; Willinger, M; Madersbacher, S
Radical prostatectomy in Austria: a nationwide analysis of 16,524 cases.
Eur Urol. 2007; 51(3):684-688
Doi: 10.1016/j.eururo.2006.06.022
Web of Science
PubMed
FullText
FullText_MUG
Walz, J; Gallina, A; Hutterer, G; Perrotte, P; Shariat, SF; Graefen, M; McCormack, M; Bénard, F; Valiquette, L; Saad, F; Karakiewicz, PI
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2007; 69(1): 88-94.
Doi: 10.1016/j.ijrobp.2007.02.022
Web of Science
PubMed
FullText
FullText_MUG
Walz, J; Gallina, A; Perrotte, P; Jeldres, C; Trinh, QD; Hutterer, GC; Traumann, M; Ramirez, A; Shariat, SF; McCormack, M; Perreault, JP; Bénard, F; Valiquette, L; Saad, F; Karakiewicz, PI
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
BJU Int. 2007; 100(6): 1254-1258.
Doi: 10.1111/j.1464-410X.2007.07130.x
Web of Science
PubMed
FullText
FullText_MUG
2003
Augustin, H; Hammerer, PG; Blonski, J; Graefen, M; Palisaar, J; Daghofer, F; Huland, H; Erbersdobler, A
Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?
UROLOGY. 2003; 62(1): 79-85.
Doi: 10.1016%2FS0090-4295%2803%2900248-6
Web of Science
PubMed
FullText
FullText_MUG
Graefen, M; Augustin, H; Karakiewicz, PI; Hammerer, PG; Haese, A; Palisaar, J; Fernandez, S; Noldus, J; Erbersdobler, A; Cagiannos, I; Scardino, PT; Kattan, MW; Huland, H
Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy
UROLOGE A. 2003; 42(5): 685-692.
Doi: 10.1007/s00120-002-0251-x
Web of Science
PubMed
FullText
FullText_MUG